PAMLAB is a specialist medical practice in Libin. Private Limited, started on 26 September 1997.

What is the address of PAMLAB?

The registered office of PAMLAB is located at Rue de Libin,Smuid 27, 6890 Libin.

Is PAMLAB still active?

Yes. According to the CBE (30 October 2026) PAMLAB is active, legal situation “Normale toestand”, started on 26 September 1997.

Is PAMLAB registered on Peppol?

Yes, PAMLAB is registered on the Peppol network with ID 0208:0461543816.

What is the enterprise number of PAMLAB?

The enterprise number of PAMLAB is BE0461543816.

When was PAMLAB founded?

PAMLAB was founded on 26 September 1997.

Who are the directors of PAMLAB?

According to the 2025 annual accounts, the directors of PAMLAB are: Antonio Seco de Seixas Pereira.

Is PAMLAB a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 September 1997; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PAMLAB make in 2025?

PAMLAB recorded a loss after taxes of € 21,930 in financial year 2025.

What is the revenue of PAMLAB?

As a small company, PAMLAB is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 5,077.

PAMLAB (Private Limited) - Libin - BE0461543816

Dossier PAMLAB, printed on 30 October 2026 from databakkes.be/en/0461543816/pamlab. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

PAMLAB from Libin, company number BE0461543816, closed financial year 2025 with a result of € -21,930 after tax. For that financial year PAMLAB recorded a gross margin of € 5,077 and equity of € 834,301. Compared with financial year 2024, the result moved from € -31,638 to € -21,930. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 834,301

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -21,930

▲ 31 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 337,250

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 821,748.

People and assets in 2025

Vehicles and equipment

€ 301

▼ 98% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 7

▼ € 2,246 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 385,027 Gross margin 2022: € 385,027 First fiscal year in the series	€ 41,242 Gross margin 2023: € 41,242 ▼ 89% vs 2022 (€ 385,027) Unfavourable step	€ 727 Gross margin 2024: € 727 ▼ 98% vs 2023 (€ 41,242) Unfavourable step	€ 5,077 Gross margin 2025: € 5,077 ▲ € 4,350 vs 2024 (€ 727) Favourable step	▲ € 4,350
Profit after taxes	€ 240,140 Profit after taxes 2022: € 240,140 First fiscal year in the series	€ 932 Profit after taxes 2023: € 932 ▼ € 239,207 vs 2022 (€ 240,140) Unfavourable step	€ -31,638 Profit after taxes 2024: € -31,638 ▼ € 32,570 vs 2023 (€ 932) Unfavourable step	€ -21,930 Profit after taxes 2025: € -21,930 ▲ € 9,708 vs 2024 (€ -31,638) Favourable step	▲ € 9,708
Equity	€ 1,130,665 Equity 2022: € 1,130,665 First fiscal year in the series	€ 1,096,887 Equity 2023: € 1,096,887 ▼ 3% vs 2022 (€ 1,130,665) Unfavourable step	€ 945,638 Equity 2024: € 945,638 ▼ 14% vs 2023 (€ 1,096,887) Unfavourable step	€ 834,301 Equity 2025: € 834,301 ▼ 12% vs 2024 (€ 945,638) Unfavourable step	▼ 12%
Total debts	€ 71,249 Total debts 2022: € 71,249 First fiscal year in the series	€ 19,249 Total debts 2023: € 19,249 ▼ 73% vs 2022 (€ 71,249) Favourable step	€ 9,398 Total debts 2024: € 9,398 ▼ 51% vs 2023 (€ 19,249) Favourable step	€ 7,327 Total debts 2025: € 7,327 ▼ 22% vs 2024 (€ 9,398) Favourable step	▼ 22%
Cash	€ 688,296 Cash 2022: € 688,296 First fiscal year in the series	€ 446,505 Cash 2023: € 446,505 ▼ 35% vs 2022 (€ 688,296) Unfavourable step	€ 407,659 Cash 2024: € 407,659 ▼ 9% vs 2023 (€ 446,505) Unfavourable step	€ 337,250 Cash 2025: € 337,250 ▼ 17% vs 2024 (€ 407,659) Unfavourable step	▼ 17%
Land & buildings	€ 336,812 Land & buildings 2022: € 336,812 First fiscal year in the series	€ 321,922 Land & buildings 2023: € 321,922 ▼ 4% vs 2022 (€ 336,812) Unchanged	€ 307,031 Land & buildings 2024: € 307,031 ▼ 5% vs 2023 (€ 321,922) Unchanged	€ 295,619 Land & buildings 2025: € 295,619 ▼ 4% vs 2024 (€ 307,031) Unchanged	▼ 4%
Retained profit	€ 1,118,112 Retained profit 2022: € 1,118,112 First fiscal year in the series	€ 1,084,334 Retained profit 2023: € 1,084,334 ▼ 3% vs 2022 (€ 1,118,112) Unfavourable step	€ 933,085 Retained profit 2024: € 933,085 ▼ 14% vs 2023 (€ 1,084,334) Unfavourable step	€ 821,748 Retained profit 2025: € 821,748 ▼ 12% vs 2024 (€ 933,085) Unfavourable step	▼ 12%
Dividend	€ 168,221 Dividend 2022: € 168,221 First fiscal year in the series	€ 34,710 Dividend 2023: € 34,710 ▼ 79% vs 2022 (€ 168,221) Unchanged	€ 119,611 Dividend 2024: € 119,611 ▲ 245% vs 2023 (€ 34,710) Unchanged	€ 89,406 Dividend 2025: € 89,406 ▼ 25% vs 2024 (€ 119,611) Unchanged	▼ 25%
Bank debt	€ 27,045 Bank debt 2022: € 27,045 First fiscal year in the series	€ 11,666 Bank debt 2023: € 11,666 ▼ 57% vs 2022 (€ 27,045) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 11,666) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,201,914 Balance sheet total 2022: € 1,201,914 First fiscal year in the series	€ 1,116,136 Balance sheet total 2023: € 1,116,136 ▼ 7% vs 2022 (€ 1,201,914) Unchanged	€ 955,035 Balance sheet total 2024: € 955,035 ▼ 14% vs 2023 (€ 1,116,136) Unchanged	€ 841,628 Balance sheet total 2025: € 841,628 ▼ 12% vs 2024 (€ 955,035) Unchanged	▼ 12%

Key figures of PAMLAB, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PAMLAB?

What happened at PAMLAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 21,930. filed late Source: NBB ↗
Sep 26, 1997 Start of the company according to the CBE. KBO

In short

From € 240,140 profit in 2022 to € 21,930 loss in 2025.

Paid € 116,692 in corporate taxes since 2022.

Best year ever: 2022, with € 240,140 profit.

Paid out € 411,949 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Antonio Seco de Seixas Pereira

PAMLAB

Behind PAMLAB is Antonio Seco de Seixas Pereira.

Directors

According to the 2025 annual accounts

Antonio Seco de Seixas Pereira

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Libin,Smuid 27

6890 Libin

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0461.543.816
VAT number: BE 0461.543.816
Registered office: Rue de Libin,Smuid 27, 6890 Libin
Names & denominations: PAMLAB
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 September 1997
Peppol: Active · Active since 25 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗